Research

Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive Multiple Sclerosis patients

NUI Galway are looking for people to take part in a new programme

iConquerMS community

Causes, attributions and intervention needs

Queens researchers in £2 million bid to reverse the damage of Multiple Sclerosis

MS Research is a brand new bi-annual research eZine. In each edition we will be sharing the latest updates from scientific and social MS research, from here in Ireland and internationally. 

Survey is now closed

Make your voice heard! 

Research showcase and 9,000 steps for MS walk

Memory, attention and concentration